Biosensia funding growth secured

TECHNOLOGY firm Biosensia has raised €2 million in a recent equity funding round for expansion.

The funding syndicate was led by venture capital firm Seroba BioVentures (Seroba) who, alongside existing investors Atlantic Bridge Ventures (ABVEN), Street Capital and Enterprise Ireland, is providing the funds for Biosensia’s expansion.

The Cork-based company has developed a hand-held point of use diagnostics instrument that allows tests to be performed and the company will initially target the drugs abuse market.